Wednesday, August 26, 2026 - The U.S. Department of Health and Human Services (HHS) has awarded Virginia Tech, based in Blacksburg, Virginia, two research related grants worth $932,292. These grants are for allergy and infectious diseases research.
The funding breakdown of the grants is as follows:
-
$199,059 for researching how bacteria interact with each other and evolve during infections that involve biofilms
-
$733,233 for researching whether the old antibiotic nitroxoline can be used for treating drug-resistant gonorrhea and chlamydia
In response to this grant notice, U.S. Congressman Morgan Griffith (R-VA) issued the following statement:
"Scientific discoveries contribute to new treatments and better health outcomes.
"These HHS grants for more than $930,000 help Virginia Tech use research to better inform American scientists, doctors and patients."
BACKGROUND
As a member of the House Committee on Energy and Commerce, Congressman Griffith serves as the Chairman of the Health Subcommittee, which has jurisdiction over the National Institutes of Health and its division of Allergy and Infectious Diseases.
###